131 related articles for article (PubMed ID: 18569005)
21. Dietary Deoxynivalenol Exposure Assessment in University Students from Japan.
Xia L; Sugita-Konishi Y; Gong Y; Routledge M
Food Saf (Tokyo); 2019 Jun; 7(2):48-53. PubMed ID: 31998586
[TBL] [Abstract][Full Text] [Related]
22. Unveiling the Broad Substrate Specificity of Deoxynivalenol Oxidation Enzyme DepA and Its Role in Detoxifying Trichothecene Mycotoxins.
Zhu Y; Chan ETS; Abraham N; Li XZ; Wang W; Mats L; Zhu H; Carere J; Zhou T
Toxins (Basel); 2024 Mar; 16(3):. PubMed ID: 38535802
[TBL] [Abstract][Full Text] [Related]
23. Simulating ozone degradation of deoxynivalenol and its bio-safety assessment by mouse model.
Sun C; Yang F; Xiao J; Zhou W; Li J; Gu X
Front Microbiol; 2023; 14():1286503. PubMed ID: 37965553
[TBL] [Abstract][Full Text] [Related]
24. Functional Agents to Biologically Control Deoxynivalenol Contamination in Cereal Grains.
Tian Y; Tan Y; Liu N; Liao Y; Sun C; Wang S; Wu A
Front Microbiol; 2016; 7():395. PubMed ID: 27064760
[TBL] [Abstract][Full Text] [Related]
25. Deoxynivalenol (DON)-Triggered Dual-Color Composite Probe Based on Gold Nanoclusters for Simultaneous Imaging of DON and miR-34a in Living Cells.
Yu W; Kang L; Lin X; Duan N; Ying D; Wang Z; Wu S
Anal Chem; 2023 Dec; 95(50):18611-18618. PubMed ID: 38057995
[TBL] [Abstract][Full Text] [Related]
26. Fusariotoxin-Induced Toxicity in Mesenchymal Stem Cells and Fibroblasts: A Comparison Between Differentiated and Undifferentiated Cells.
Shikhaliyeva I; Kığ C; Gömeç ÖY; Albayrak G
Turk J Pharm Sci; 2024 Mar; 21(1):62-70. PubMed ID: 38529558
[TBL] [Abstract][Full Text] [Related]
27. Advancing probabilistic risk assessment by integrating human biomonitoring, new approach methods, and Bayesian modeling: A case study with the mycotoxin deoxynivalenol.
Lu EH; Grimm FA; Rusyn I; De Saeger S; De Boevre M; Chiu WA
Environ Int; 2023 Dec; 182():108326. PubMed ID: 38000237
[TBL] [Abstract][Full Text] [Related]
28. Low-dose deoxynivalenol exposure inhibits hepatic mitophagy and hesperidin reverses this phenomenon by activating SIRT1.
Chen H; Xin W; Jiang J; Shan A; Ma J
J Hazard Mater; 2024 Apr; 468():133854. PubMed ID: 38401214
[TBL] [Abstract][Full Text] [Related]
29. Prediction of Deoxynivalenol Contamination in Wheat via Infrared Attenuated Total Reflection Spectroscopy and Multivariate Data Analysis.
Fomina P; Femenias A; Tafintseva V; Freitag S; Sulyok M; Aledda M; Kohler A; Krska R; Mizaikoff B
ACS Food Sci Technol; 2024 Apr; 4(4):895-904. PubMed ID: 38660051
[TBL] [Abstract][Full Text] [Related]
30. Adverse associations between maternal deoxynivalenol exposure and birth outcomes: a prospective cohort study in China.
Tan T; Chen T; Zhu W; Gong L; Yan Y; Li Q; Chen L; Li Y; Liu J; Li Y; Yang X; Hao L; Wang H; Yang N; Wei S
BMC Med; 2023 Aug; 21(1):328. PubMed ID: 37635232
[TBL] [Abstract][Full Text] [Related]
31. Development and Limitations of Exposure Biomarkers to Dietary Contaminants Mycotoxins.
Turner PC; Snyder JA
Toxins (Basel); 2021 Apr; 13(5):. PubMed ID: 33924868
[TBL] [Abstract][Full Text] [Related]
32. Biomonitoring of Multiple Mycotoxins in Urine by GC-MS/MS: A Pilot Study on Patients with Esophageal Cancer in Golestan Province, Northeastern Iran.
Niknejad F; Escrivá L; Adel Rad KB; Khoshnia M; Barba FJ; Berrada H
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33805401
[TBL] [Abstract][Full Text] [Related]
33. Human Mycotoxin Biomonitoring: Conclusive Remarks on Direct or Indirect Assessment of Urinary Deoxynivalenol.
Vidal A; Bouzaghnane N; De Saeger S; De Boevre M
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32102452
[TBL] [Abstract][Full Text] [Related]
34. Determination of Deoxynivalenol Biomarkers in Italian Urine Samples.
De Santis B; Debegnach F; Miano B; Moretti G; Sonego E; Chiaretti A; Buonsenso D; Brera C
Toxins (Basel); 2019 Jul; 11(8):. PubMed ID: 31349679
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Phase I and Glucuronide Phase II Metabolites of 17 Mycotoxins Using Liquid Chromatography-High-Resolution Mass Spectrometry.
Slobodchikova I; Sivakumar R; Rahman MS; Vuckovic D
Toxins (Basel); 2019 Jul; 11(8):. PubMed ID: 31344861
[TBL] [Abstract][Full Text] [Related]
36. Biomonitoring Study of Deoxynivalenol Exposure in Chinese Inhabitants.
Wang X; Liang J; Cao P; Zhou S; Wu A; Gao P; Xu H; Liu Z; Gong Y
Int J Environ Res Public Health; 2019 Jun; 16(12):. PubMed ID: 31248171
[No Abstract] [Full Text] [Related]
37. Humans significantly metabolize and excrete the mycotoxin deoxynivalenol and its modified form deoxynivalenol-3-glucoside within 24 hours.
Vidal A; Claeys L; Mengelers M; Vanhoorne V; Vervaet C; Huybrechts B; De Saeger S; De Boevre M
Sci Rep; 2018 Mar; 8(1):5255. PubMed ID: 29588479
[TBL] [Abstract][Full Text] [Related]
38. Assessment of Urinary Deoxynivalenol Biomarkers in UK Children and Adolescents.
Papageorgiou M; Wells L; Williams C; White K; De Santis B; Liu Y; Debegnach F; Miano B; Moretti G; Greetham S; Brera C; Atkin SL; Hardie LJ; Sathyapalan T
Toxins (Basel); 2018 Jan; 10(2):. PubMed ID: 29360781
[TBL] [Abstract][Full Text] [Related]
39. Mycotoxin binder improves growth rate in piglets associated with reduction of toll-like receptor-4 and increase of tight junction protein gene expression in gut mucosa.
Jin L; Wang W; Degroote J; Van Noten N; Yan H; Majdeddin M; Van Poucke M; Peelman L; Goderis A; Van De Mierop K; Mombaerts R; De Smet S; Michiels J
J Anim Sci Biotechnol; 2017; 8():80. PubMed ID: 29118977
[TBL] [Abstract][Full Text] [Related]
40. Deoxynivalenol Biomarkers in the Urine of UK Vegetarians.
Wells L; Hardie L; Williams C; White K; Liu Y; De Santis B; Debegnach F; Moretti G; Greetham S; Brera C; Papageorgiou M; Thatcher NJ; Rigby A; Atkin SL; Sathyapalan T
Toxins (Basel); 2017 Jun; 9(7):. PubMed ID: 28640201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]